BUGDF (Bumrungrad Hospital PCL) EV-to-EBITDA: 12.53 (As of Jul. 08, 2026) — 48% Below Median


BUGDF Bumrungrad Hospital PCL BUGDF
100 GF Score
Price $4.75
GF Value $5.35
! 2 Warning Signs
View Full Analysis

What is Bumrungrad Hospital PCL EV-to-EBITDA?

Bumrungrad Hospital PCL BUGDF 100 EV-to-EBITDA is 12.53 as of Jul. 08, 2026, which is 48% below its 10-year median of 23.99. GuruFocus rates BUGDF with a GF Score™ of 100/100 and a GF Value™ of $5.35. The stock has 2 warning signs investors should review. Among 505 Healthcare Providers & Services companies, Bumrungrad Hospital PCL ranks worse than 58.22% on this metric.

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bumrungrad Hospital PCL's enterprise value is $4,097.1 Mil. Bumrungrad Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $326.9 Mil. Therefore, Bumrungrad Hospital PCL's EV-to-EBITDA for today is 12.53.

The historical rank and industry rank for Bumrungrad Hospital PCL's EV-to-EBITDA or its related term are showing as below:

BUGDF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.91   Med: 23.99   Max: 62.7
Current: 13.15

During the past 13 years, the highest EV-to-EBITDA of Bumrungrad Hospital PCL was 62.70. The lowest was 9.91. And the median was 23.99.

BUGDF's EV-to-EBITDA is ranked worse than
58.22% of 505 companies
in the Healthcare Providers & Services industry
Industry Median: 10.95 vs BUGDF: 13.15

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-07-08), Bumrungrad Hospital PCL's stock price is $4.75. Bumrungrad Hospital PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.273. Therefore, Bumrungrad Hospital PCL's PE Ratio (TTM) for today is 17.40.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Bumrungrad Hospital PCL  (OTCPK:BUGDF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Bumrungrad Hospital PCL's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.75/0.273
=17.40

Bumrungrad Hospital PCL's share price for today is $4.75.
Bumrungrad Hospital PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.273.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Bumrungrad Hospital PCL EV-to-EBITDA Related Terms


Bumrungrad Hospital PCL EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Bumrungrad Hospital PCL's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bumrungrad Hospital PCL EV-to-EBITDA Chart

Bumrungrad Hospital PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.66 22.40 17.06 13.96 10.76

Bumrungrad Hospital PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.51 9.78 12.44 10.76 11.03

BUGDF vs HCA, THC, DVA: EV-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bumrungrad Hospital PCL EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bumrungrad Hospital PCL's EV-to-EBITDA falls into.


BUGDF
100GF Score
Bumrungrad Hospital PCL BUGDF
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bumrungrad Hospital PCL EV-to-EBITDA Calculation

Bumrungrad Hospital PCL's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4097.107/326.917
=12.53

Bumrungrad Hospital PCL's current Enterprise Value is $4,097.1 Mil.
Bumrungrad Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $326.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBITDA →
What does a EV-to-EBITDA of 12.53 mean?
Bumrungrad Hospital PCL (BUGDF) has a EV-to-EBITDA of 12.53 as of Jul. 08, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bumrungrad Hospital PCL. This is 48% below median its historical median of 23.99. Over the past decade, Bumrungrad Hospital PCL's EV-to-EBITDA has ranged from 9.91 to 62.70. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #294 out of 505 companies in the Healthcare Providers & Services industry, placing it in the top 58.2%.
Is Bumrungrad Hospital PCL's EV-to-EBITDA too high?
Bumrungrad Hospital PCL's current EV-to-EBITDA of 12.53 is 48% below median its 10-year median of 23.99. Over the past 10 years, this metric has ranged from a low of 9.91 to a high of 62.70. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.95. Bumrungrad Hospital PCL's value of 12.53 is 14.4% above this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #294 out of 505 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #294 out of 505 companies for EV-to-EBITDA. This places Bumrungrad Hospital PCL in the lower half of its industry. The industry median EV-to-EBITDA is 10.95. Bumrungrad Hospital PCL's value of 12.53 is 14.4% above this benchmark. Historically, Bumrungrad Hospital PCL's own EV-to-EBITDA has ranged from 9.91 to 62.70 over the past decade. While the company's 10-year median is 23.99 vs. the industry median of 10.95, Bumrungrad Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.95, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current EV-to-EBITDA of 12.53 is 14.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bumrungrad Hospital PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current EV-to-EBITDA is 12.53, which is 48% below median its own 10-year median of 23.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current EV-to-EBITDA of 12.53. The stock's GF Value™ is $5.35, compared to a current price of $4.75 — trading 11.2% below its estimated fair value. The current EV-to-EBITDA is 12.53, which is 48% below median its 10-year median of 23.99 and 14.4% above the Healthcare Providers & Services industry median of 10.95. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current EV-to-EBITDA is 12.53 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued. The current stock price of $4.75 is trading 11.2% below its estimated GF Value™ of $5.35.

Key valuation signals for BUGDF:

  • EV-to-EBITDA: 12.53 (48% below median its 10-year median of 23.99)
  • GF Value™: $5.35 vs. price of $4.75 (11.2% below fair value)
  • GF Score™: 100/100 with 2 warning signs
  • Industry Position: 14.4% above the Healthcare Providers & Services median (#294 of 505)

No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bumrungrad Hospital PCL Business Description

Other Exchanges BH:ThailandBZ7A:Germany
Address 33 Soi 3 (Nana Nua) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok, THA, 10110
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score

Get the complete analysis for BUGDF

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.75
Price
$5.35
GF Value